Evidence map›Paper›PMID 30147699›Full record

ArticleFrontiers in immunology2018

KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in

Xin Zhang, Xiaofan Lu, Christiane Moog, Lin Yuan, Zhiying Liu, Zhen Li, Wei Xia, Yuefang Zhou, Hao Wu, Tong Zhang and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. HIV controllers: hope for a functional cure.Frontiers in immunology · 2025
    Review
  4. Review
  5. CD56International journal of general medicine · 2022
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Xin ZhangCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Xiaofan LuCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Christiane MoogINSERM U1109, Fédération Hospitalo-Universitaire (FHU) OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France.
Lin YuanCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Zhiying LiuCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Zhen LiCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Wei XiaCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Yuefang ZhouCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Hao WuCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Tong ZhangCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Bin SuCenter for Infectious Diseases, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing YouAn Hospital · CNFédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntigens, CDAntigens, Differentiation, T-LymphocyteCD4 Lymphocyte CountCD69 AntigensCD8-Positive T-LymphocytesCells, CulturedCohort StudiesEnzyme-Linked Immunospot AssayFemaleFollow-Up StudiesHIV-1HIV InfectionsHLA-B AntigensHomozygoteHumansAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensHLA-B AntigensHLA-Bw4 antigenHLA-Bw6 antigenKIR3DL1 protein, humanLectins, C-TypeReceptors, KIR3DL1acute/early infectionBw4 homozygoteshuman immunodeficiency virus type 1immunityKIR3DL1 receptor

Identifiers

PMID30147699
PMCPMC6096002
OpenAlexW2886582443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.